NICE completes Forxiga U-turn
June 26, 2013Sales and Marketing BMS, Forxiga, NICE
Bristol-Myers Squibb and AstraZeneca are celebrating after NICE reversed its decision from earlier this year and is now recommending their …
Merck Serono censured over calls
June 25, 2013Medical Communications, Sales and Marketing ABPI, Erbitux, Merck Serono, PMCPA
A Merck Serono medical representative has been accused of ‘harassing’ an anonymous health professional by requesting a meeting every month …
Lilly diabetes drug beats rivals
June 25, 2013Sales and Marketing BMS, diabetes, dulaglutide, lilly
New clinical trial results have shown Lilly’s investigational type 2 diabetes drug has beaten its three nearest rivals in reducing …
Roger Graham appointed president of Mylan Specialty
June 25, 2013Manufacturing and Production, Research and Development, Sales and Marketing Mylan, graham, specialty
Mylan has hired previous J&J vice president Roger Graham to be president of its specialty business. Graham will report to …
US gains exemption from EU requirements on API imports
June 25, 2013Manufacturing and Production API, FDA, hamburg
The US has joined the short list of countries from which suppliers can ship active pharmaceutical ingredients into the EU …
GSK mulling sales of thrombosis brands and facility to Aspen
June 24, 2013Manufacturing and Production, Sales and Marketing Arixtra, GSK, aspen
GlaxoSmithKline says it is considering an offer from South African drugmaker Aspen Pharmacare to take ownership of two thrombosis drugs …
BMS appoints Harman International chief executive
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing BMS
Bristol-Myers Squibb has appointed Harman’s chief executive Dinesh Paliwal to its Board of directors.Paliwal will serve as a member of …
Viagra patent expiry opens up market
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing ED, Pfizer, generics, viagra
Pfizer lost its UK patent rights to its erectile dysfunction drug Viagra over the weekend, leading to an influx of …
Lundbeck cuts more jobs in Europe
June 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing Lexapro, Lundbeck, cuts
Lundbeck is to cut yet more jobs in Europe as the Danish pharma firm restructures its operations to focus on …
David Haslam: a new chairman for a new NICE
June 24, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Hasmam, NHS, NICE
When NICE was first set up in 1999, technology appraisals of new medicines were its sole focus, but over the …
CQC revelations continue
June 21, 2013Sales and Marketing CQC, NHS, NICE
The turmoil at the Care Quality Commission (CQC) shows no sign of abating as MPs may summon the current leadership …
J&J opens office at Stevenage Bioscience Catalyst
June 21, 2013Manufacturing and Production, Research and Development J&J, JJ, bioscience, catalyst
Johnson & Johnson Innovation has establishment a partnering office at Stevenage Bioscience Catalyst to support emerging entrepreneurs and biotech firms …
Zaltrap ‘no’ from NICE
June 21, 2013Sales and Marketing NICE, Sanofi, Zaltrap
NICE is preparing to discard Sanofi’s Zaltrap as an NHS option for treating metastatic colorectal cancer (mCRC) that is resistant …
UK government keen to reduce drugs bill
June 21, 2013Sales and Marketing NHS, NICE, UK, VBP
The government has shown its hand in the drug pricing debate after asking for a 20% price cut on some …
John Garibotto joins Cellnovo’s Board
June 21, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cellnovo, Garibotto
UK-based medical device firm Cellnovo has appointed John Garibotto as a non-executive director. Garibotto is a 20-year veteran of the …
UK takes action to prevent API shortages
June 20, 2013Manufacturing and Production API, MHRA, shortages
The UK has unilaterally adopted a policy of allowing imports of active pharmaceutical ingredients (API) on the strength of pharmaceutical …
Sanofi makes Curie cancer deal
June 20, 2013Research and Development, Sales and Marketing Cancer, R&D, Sanofi, curie
Sanofi has signed a three-year research collaboration with the Curie Institute to identify new therapeutic targets which will help develop …
InHealthcare appoints NHS director
June 20, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing InHealthcare
Digital healthcare firm InHealthcare has appointed NHS director Simon Jones as its new commercial director.Jones has held positions in Acute Hospitals, Mental Health and …
Nine fined in EU pay-for-delay deals
June 20, 2013Manufacturing and Production, Sales and Marketing EU, Lundbeck, Merck, Ranbaxy
Nine pharma firms have been handed hefty fines by the European Commission over allegations that they willingly blocked generic versions …
CQC embroiled in ‘cover up’ row
June 20, 2013Sales and Marketing Mid Staffs, NHS. CQC, UHMB
The organisation responsible for inspecting health and care standards in the NHS is at the centre of a flaming political …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
